Lack of modulatory effect of simvastatin on indoxyl sulfate-induced activation of cultured endothelial cells

Life Sciences

Volumn 90, Issue 1-2, 2012, Pages 47-53

  Lee, Chien Te ^a   Lee, Yueh Ting ^a   Ng, Hwee Yeong ^a   Chiou, Terry Ting Yu ^a   Cheng, Cheng I ^b   Kuo, Chien Chun ^a   Wu, Chien Hsing ^a   Chi, Po Jui ^a   Lee, Wen Chin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Adhesion molecule; Endothelial cell; Indoxyl sulfate; Statins

Indexed keywords

ANGIOTENSIN RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDICAN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL CULTURE; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD46; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INDICAN; INTERCELLULAR ADHESION MOLECULE-1; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84655160816     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.10.014     Document Type: Article

References (30)

1. K. Almuti, R. Rimawi, D. Spevack, and R.J. Ostfeld Effects of statins beyond lipid lowering: potential for clinical benefits Int J Cardiol 109 1 2005 7 15
2. B. Bammens, P. Evenepoel, H. Keuleers, K. Verbeke, and Y. Vanrenterghem Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients Kidney Int 69 6 2006 1081 1087 (Pubitemid 43372184)
3. F.C. Barreto, D.V. Barreto, S. Liabeuf, N. Meert, G. Glorieux, M. Temmar, G. Choukroun, R. Vanholder, and Z.A. Massy Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients Clin J Am Soc Nephrol 4 10 2009 1551 1558
4. U.C. Brewster, and M.A. Perazella The rennin-angiotensin-aldosterone system and the kidney: effects on kidney disease Am J Med 116 4 2004 263 272 (Pubitemid 38224234)
5. K. Douglas, P.G. O'Malley, and J.L. Jackson Meta-analysis: the effect of statins on albuminuria Ann Intern Med 145 2 2006 117 124 (Pubitemid 46780585)
6. M. Feletou, and P.M. Vanhoutte Endothelial dysfunction: a multifaceted disorder Am J Physiol Heart Circ Physiol 291 3 2006 H985 H1002
7. B.C. Fellström, A.G. Jardine, R.E. Schmieder, H. Holdaas, K. Bannister, J. Beutler, D.W. Chae, A. Chevaile, S.M. Cobbe, C. Grönhagen-Riska, J.J. De Lima, R. Lins, G. Mayer, A.W. Mc Mahon, H.H. Parving, G. Remuzzi, O. Samuelsson, S. Sonkodi, D. Sci, G. Süleymanlar, D. Tsakiris, V. Tesar, V. Todorov, A. Wiecek, R.P. Wüthrich, M. Gottlow, E. Johnsson, and F. Zannad Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 1395 1407
8. R.N. Foley, A.M. Murray, S. Li, C.A. Herzog, A.M. McBean, P.W. Eggers, and A.J. Collins Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999 J Am Soc Nephrol 16 2 2005 489 495 (Pubitemid 41725146)
9. J. Fort Chronic renal failure: a cardiovascular risk factor Kidney Int Suppl 99 2005 S25 S29
10. M.S. Goligorsky Clinical assessment of endothelial dysfunction: combine and rule Curr Opin Nephrol Hypertens 15 6 2006 617 624 (Pubitemid 44607434)
11. S. Ito, M. Osaka, Y. Higuchi, F. Nishijima, H. Ishii, and M. Yoshida Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin J Biol Chem 285 50 2010 38869 38875
12. T.H. Le, and T.M. Coffman Targeting genes in the rennin-angiotensin system Curr Opin Nephrol Hypertens 17 1 2008 57 63
13. C.T. Lee, C.C. Kuo, Y.M. Chen, C.Y. Hsu, W.C. Lee, Y.C. Tsai, H.Y. Ng, L.C. Kuo, T.T. Chiou, Y.K. Yang, B.C. Cheng, and J.B. Chen Factors associated with blood concentration of indoxyl sulfate and p-cresol in peritoneal dialysis patients Perit Dial Int 30 4 2010 456 463
14. S. Lekawanvijit, A. Adrahtas, D.J. Kelly, A.R. Kompa, B.H. Wang, and H. Krum Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes Eur Heart J 31 14 2010 1771 1779
15. Y.J. Liang, K.G. Shyu, B.W. Wang, and L.P. Lai Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products Cardiology 110 3 2008 182 190
16. B.K. Meijers, K. Claes, B. Bammens, H. de Loor, L. Viaene, K. Verbeke, D. Kuypers, Y. Vanrenterghem, and P. Evenepoel p-Cresol and cardiovascular risk in mild-to-moderate kidney disease Clin J Am Soc Nephrol 5 7 2010 1182 1189
17. G. Muteliefu, A. Enomoto, P. Jiang, M. Takahashi, and T. Niwa Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells Nephrol Dial Transplant 24 7 2009 2051 2058
18. T. Nii-Kono, Y. Iwasaki, M. Uchida, A. Fujieda, A. Hosokawa, M. Motojima, H. Yamato, K. Kurokawa, and M. Fukagawa Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells Kidney Int 71 8 2007 738 743 (Pubitemid 46624017)
19. T. Niwa, T. Nomura, S. Sugiyama, T. Miyazaki, S. Tsukushi, and S. Tsutsui The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients Kidney Int Suppl 62 1997 S23 S28
20. T.J. Rabelink, H.C. de Boer, and A.J. van Zonneveld Endothelial activation and circulating markers of endothelial activation in kidney disease Nat Rev Nephrol 6 7 2010 404 414
21. C.A. Schaefer, C.R. Kuhlmann, C. Gast, S. Weiterer, F. Li, A.K. Most, T. Neumann, U. Backenköhler, H. Tillmanns, B. Waldecker, J. Wiecha, and A. Erdogan Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells Vascul Pharmacol 41 2 2004 67 73 (Pubitemid 38757759)
22. D. Skultetyova, S. Filipova, I. Riecansky, and J. Skultety The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction Recent Pat Cardiovasc Drug Discov 2 1 2007 23 27 (Pubitemid 46813412)
23. Z. Tumur, and T. Niwa Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells Am J Nephrol 29 6 2009 551 557
24. Z. Tumur, H. Shimizu, A. Enomoto, H. Miyazaki, and T. Niwa Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation Am J Nephrol 31 5 2010 435 441
25. R. Vanholder, U. Baurmeister, P. Brunet, G. Cohen, G. Glorieux, and J. Jankowski A bench to bedside view of uremic toxins J Am Soc Nephrol 19 5 2008 863 870
26. R. Vanholder, S. Van Laecke, and G. Glorieux What is new in uremic toxicity? Pediatr Nephrol 23 8 2008 1211 1221
27. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol Med 14 1 2008 37 44
28. C. Wanner, V. Krane, W. März, M. Olschewski, J.F. Mann, G. Ruf, and E. Ritz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 2005 238 248 (Pubitemid 41058323)
29. J.R. Wu-Wong Endothelial dysfunction and chronic kidney disease: treatment options Curr Opin Investig Drugs 9 9 2008 970 982
30. D. Zapolska-Downar, A. Siennicka, M. Kaczmarczyk, B. Kołodziej, and M. Naruszewicz Simvastatin modulates TNF alpha-induced adhesion molecules expression in human endothelial cells Life Sci 75 11 2004 1287 1302 (Pubitemid 38845028)